4′-Substituted nucleoside derivatives as inhibitors of HCV RNA replication
US7608601B2 · kind B2 · utility
43Cited by
5References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 15, 2004 |
| Grant date | Oct 27, 2009 |
| Priority date | — |
| Expiry date | Mar 1, 2026 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/582
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of nucleoside derivatives of formula I
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.